Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Ajoene is a sulfur-containing compound derived from garlic (Allium sativum) and has been studied for its potential cardiovascular benefits, including effects relevant to arteriosclerosis. The scientific rationale for ajoene's use in arteriosclerosis centers around its antiplatelet, anti-inflammatory, and cholesterol-lowering activities. Several in vitro and animal studies have shown that ajoene can inhibit platelet aggregation by blocking fibrinogen binding and affecting thromboxane synthesis, potentially reducing the risk of thrombosis associated with arteriosclerosis. Additionally, ajoene possesses antioxidant properties, which may help mitigate oxidative stress involved in arterial plaque formation and progression. Some research also suggests ajoene can modestly lower cholesterol levels and inhibit smooth muscle cell proliferation, both factors in the development of arteriosclerosis. However, the evidence supporting ajoene's effectiveness in treating or preventing arteriosclerosis in humans is limited. Most of the data come from laboratory or animal models, with only a few small-scale or preliminary clinical studies available. These studies have shown some promising results, but larger, well-controlled clinical trials are lacking. Therefore, while ajoene's biological activities align with mechanisms implicated in arteriosclerosis, its use for this condition is not robustly supported by high-quality clinical evidence. As such, its evidence rating is moderate to low. Further research is needed to confirm whether ajoene can be safely and effectively used as a therapeutic agent in arteriosclerosis management.

More about Ajoene
More about Arteriosclerosis

Other ingredients used for Arteriosclerosis

Other health conditions supported by Ajoene

Products containing Ajoene

Designs For Health Allicillin™